Novo Nordisk’s Wegovy gets UK regulator nod to treat heart risks
The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.
About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and.
HQ Team May 7, 2024: Anger, for just a few minutes, and the associated stress, depression and anxiety can lead to adverse cardiovascular.
HQ Team March 18, 2023: Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease.
HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian..
HQ Team October 2, 2023: Walking more than five flights of stairs a day can cut the risk of heart disease by 20%,.
HQ Team September 5, 2023: Australian researchers have discovered an oral drug to treat excess bad cholesterol in the blood, a condition that.
HQ Team August 9, 2023: The brain’s hypothalamus gland is a relevant factor in obesity and little is known about how this region.
HQ Team May 3, 2023: Researchers at the University of Michigan and the University of British Columbia have developed a new blood thinner.
An artificial intelligence-powered machine can reduce the treatment time for stroke patients by 60 minutes and free up clinicians’ time.